abstract |
The present invention is drawn to new peptides and proteins that bind to human insulin-like growth factor- 1 receptor (HIGF-IR), as well as nucleic acids encoding the same, vectors and cells comprising such nucleic acids, pharmaceutical compositions comprising such compounds, and methods of using any thereof, are provided. |